Christine Højte
Enrolled PhD student
Lifecourse Nutrition & Health
Rolighedsvej 26
1958 Frederiksberg C
ORCID: 0000-0002-0970-4077
1 - 3 out of 3Page size: 10
- 2024
- Accepted/In press
Real-world data confirm elexacftor/tezacaftor/ivacaftor modulators halves sweat chloride concentration in eligible people with cystic fibrosis
the TransformCF study group, T. T. S. G., 2024, (Accepted/In press) In: APMIS.Research output: Contribution to journal › Journal article › Research › peer-review
- 2023
- Published
Changes in glucose tolerance in people with cystic fibrosis after initiation of first-generation CFTR modulator treatment
Ekblond, R. S., Nielsen, B. U., Højte, Christine, Almdal, Thomas Peter, Shaw, J., Pressler, T., Faurholt-Jepsen, Daniel & Mathiesen, I. H. M., 2023, In: Pediatric Pulmonology. 58, 9, p. 2600-2609 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
- 2019
Late diagnosis and poor nutrition in cystic fibrosis diagnosed before implementation of newborn screening.
Pedersen, M. G., Højte, Christine, Olesen, H. V., Pressler, T. & Skov, M., 2019, In: Acta Paediatrica. 108, 12, p. 2241-2245 5 p.Research output: Contribution to journal › Journal article › Research › peer-review
ID: 292041761
Most downloads
-
27
downloads
Changes in glucose tolerance in people with cystic fibrosis after initiation of first-generation CFTR modulator treatment
Research output: Contribution to journal › Journal article › Research › peer-review
Published